Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00527514 · ClinicalTrials.gov registry record · Phase 3
Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension
A Phase 3 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 3
- Development phase
- 185
- Enrollment target
NCT00527514 is a Phase 3 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 185 participants.
The verdict
NCT00527514, a Phase 3 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 185 participants
- Enrollment target
Study Summary
This study will be conducted to assess the efficacy and safety of an amlodipine/olmesartan treatment regimen in stage 1 and stage 2 hypertensive subjects.
Interventions
- DRUG Amlodipine
- DRUG Olmesartan medoxomil plus amlodipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00527514
The ClinicalTrials.gov registry entry for NCT00527514 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amlodipine is the first listed.
NCT00527514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00527514 about?
NCT00527514 is a clinical study titled "Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension". This study will be conducted to assess the efficacy and safety of an amlodipine/olmesartan treatment regimen in stage 1 and stage 2 hypertensive subjects.
What is the current status of trial NCT00527514?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 185 participants. The study started on 2007-09. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00527514?
The interventions under investigation include: Amlodipine (DRUG), Olmesartan medoxomil plus amlodipine (DRUG).
Who is sponsoring clinical trial NCT00527514?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.